ATI Pharmacology

Questions 121

ATI RN

ATI RN Test Bank

ATI Pharmacology Questions

Question 1 of 5

A client with increased intracranial pressure is receiving Mannitol. Which finding should the nurse report to the provider?

Correct Answer: C

Rationale: Dyspnea is a concerning finding in a client receiving Mannitol as it can be a manifestation of heart failure, an adverse effect of the medication. The nurse should report this to the provider promptly to ensure appropriate evaluation and management.

Question 2 of 5

A healthcare professional is caring for a client who is prescribed Digoxin. Which of the following findings should the healthcare professional monitor to assess for potential toxicity?

Correct Answer: A

Rationale: Bradycardia is a common sign of Digoxin toxicity. Digoxin can cause bradycardia due to its effects on the heart's electrical conduction system. Monitoring the client's heart rate regularly is essential to detect and manage toxicity promptly.

Question 3 of 5

A nurse is teaching a female client who has tobacco use disorder about Nicotine replacement therapy. Which of the following statements by the client indicates understanding of the teaching?

Correct Answer: A

Rationale: The client should avoid eating or drinking 15 min prior to and while chewing the nicotine gum.

Question 4 of 5

A client has a new prescription for a Nitroglycerin transdermal patch for Angina Pectoris. Which of the following instructions should the nurse include?

Correct Answer: A

Rationale: The correct instruction for a client using a Nitroglycerin transdermal patch is to remove the patch each evening to prevent tolerance. This allows for a nitrate-free period of 10 to 12 hours during each 24-hour period, reducing the risk of developing tolerance to the medication.

Question 5 of 5

When starting therapy with bicalutamide, a client should be instructed to monitor for which of the following adverse effects?

Correct Answer: C

Rationale: The correct answer is C: Gynecomastia. Bicalutamide, due to its antiandrogenic properties, can lead to gynecomastia in clients. This condition involves the development of breast tissue in males and is an important adverse effect to monitor when taking this medication.

Similar Questions

Join Our Community Today!

Join Over 10,000+ nursing students using Nurselytic. Access Comprehensive study Guides curriculum for ATI-RN and 3000+ practice questions to help you pass your ATI-RN exam.

Call to Action Image